• PHP58 FACTORS ASSOCIATED WITH REPEAT ATTENDANCE AT EMERGENCY DEPARTMENT (ED) OF A SECONDARY CARE HOSPITAL IN SINGAPORE

    May 1, 2009, 00:00

  • PCN54 COST-MINIMIZATION ANALYSIS OF FLUDARABINE ASSOCIATED TO ALEMTUZUMAB (FLUCAM) VERSUS THE ASSOCIATION OF FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB (FCR) IN THE SECOND LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) UNDER THE BRAZ ...

    May 1, 2009, 00:00

  • ND2 DIRECT HEALTH CARE AND WORKLOSS BURDEN OF CHEMOTHERAPY-ASSOCIATED PERIPHERAL NEUROPATHY IN BREAST, OVARIAN, HEAD AND NECK, AND NON-SMALL CELL LUNG CANCER

    May 1, 2009, 00:00

  • PDB56 THE EFFECT OF VALUE-BASED INSURANCE DESIGN ON ADHERENCE TO DIABETES MEDICATIONS- A MATCHED DIFFERENCE IN DIFFERENCE EVALUATION

    May 1, 2009, 00:00

  • PCN58 HEALTH CARE COSTS IN WOMEN WITH INCIDENT METASTATIC BREAST CANCER RECEIVING CHEMOTHERAPY AS THEIR PRINCIPAL TREATMENT MODALITY

    May 1, 2009, 00:00

  • PMH62 PREDICTORS OF OUTPATIENTS VISITS AND EMERGENCY ROOM VISITS IN PATIENTS WITH EARLY PSYCHOTIC ILLNESS

    May 1, 2009, 00:00

  • PMS11 RELATIONSHIP BETWEEN LEVELS OF PHYSICAL ACTIVITY AT WORK AND PREVALENCE OF ARTHRITIS AMONG WORKING POPULATION

    May 1, 2009, 00:00

  • FD2 ORPHAN DRUGS MARKET ACCESS IN THE UNITED STATES

    May 1, 2009, 00:00

  • PMH35 NATIONAL ESTIMATES OF HEALTH SERVICE USE AND COSTS IN CHRONIC MEDICAL DISORDER PATIENTS WITH AND WITHOUT DEPRESSION IN 2004-5

    May 1, 2009, 00:00

  • PCV11 POINT-OF-CARE INR MONITORING DEVICES FOR PATIENTS ON LONG-TERM ORAL ANTICOAGULATION THERAPY

    May 1, 2009, 00:00

  • PCN75 THE IMPACT OF NEUTROPENIC COMPLICATIONS ON SHORT-TERM DISABILITY IN PATIENTS WITH CANCER RECEIVING CHEMOTHERAPY

    May 1, 2009, 00:00

  • PRS33 MEASUREMENT OF QUALITY OF LIFE BY EQ-5D IN PROLONGED MECHANICAL VENTILATION PATIENTS- COMPARISON BETWEEN PATIENTS AND PROXIES

    May 1, 2009, 00:00

  • PMC10 COMPARISON BETWEEN PROPENSITY SCORE AND TRADITIONAL COVARIATE ADJUSTMENT WITH LOGISTIC REGRESSION MODELS IN ESTIMATING THE AVERAGE TREATMENT EFFECTS (ATES)- RESULTS FROM MONTE CARLO SIMULATIONS

    May 1, 2009, 00:00

  • PDB24 COMPARISON OF GLUCOMETERS USED FOR SELF-MONITORING BLOOD GLUCOSE AMONG DIABETIC PATIENTS- A COST MINIMIZATION APPROACH.

    May 1, 2009, 00:00

  • PCN48 THE COST-EFFECTIVENESS OF BORTEZOMIB FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA IN SWEDEN

    May 1, 2009, 00:00

  • PHP21 USING EXPLICIT CRITERIA TO EVALUATE INAPPROPRIATE PRESCRIBING IN ELDERLY OUTPATIENTS- A COHORT STUDY

    May 1, 2009, 00:00

  • PHP81 ADDRESSING THE CHALLENGE OF IMPLEMENTING HEALTH TECHNOLOGIES- THE SPANISH EXPERIENCE

    May 1, 2009, 00:00

  • PHP34 A NEW INEQUITY-IN-HEALTH INDEX BASED ON MILLENIUM DEVELOPMENT GOALS- METHODOLOGY AND VALIDATION

    May 1, 2009, 00:00

  • PRS34 EQ-5D BASED QOL ASSESSMENT IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASES (COPD) IN JAPAN

    May 1, 2009, 00:00

  • PRS46 ASSESSING ASTHMA MANAGEMENT IN AN URBAN COMMUNITY IN DELHI, INDIA

    May 1, 2009, 00:00

  • PMH54 PATIENT-REPORTED HEALTH STATUS IN CHRONIC MEDICAL DISORDER PATIENTS WITH AND WITHOUT DEPRESSION IN THE UNITED STATES, 2004-2005

    May 1, 2009, 00:00

  • PDB30 IMPROVEMENT IN CARDIOVASCULAR RISK FACTORS AND LONG-TERM OUTCOMES IN PEOPLE WITH TYPE 2 DIABETES TREATED WITH LIRAGLUTIDE OR GLIMEPIRIDE MONOTHERAPY

    May 1, 2009, 00:00

  • PCN33 COST-EFFECTIVENESS ANALYSIS OF SORAFENIB ASSOCIATED TO BEST SUPPORTIVE CARE (BSC) VERSUS BEST SUPPORTIVE CARE ALONE IN THE SECOND LINE TREATMENT OF ADVANCED RENAL CELL CARCINOMA UNDER THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM PERSPECTIV ...

    May 1, 2009, 00:00

  • PHP31 VARIABILITY OF FEES IN THE FIELD OF ULTRASOUND IN THE AUSTRIAN CONTRACTED PHYSICIANS SECTOR

    May 1, 2009, 00:00

  • PCV60 ECONOMIC ANALYSIS OF ENDEAVOR VS. CYPHER STENTS- RESULTS FROM THE ENDEAVOR III TRIAL

    May 1, 2009, 00:00

  • PRS9 MANAGED-CARE BUDGET IMPACT OF OMALIZUMAB FOR MODERATE TO SEVERE PERSISTENT ASTHMA

    May 1, 2009, 00:00

  • PMH27 INPATIENT COST OF SCHIZOPHRENIA TREATMENT IN TURKEY

    May 1, 2009, 00:00

  • PHP64 LINKING PAYMENT AND HEALTH OUTCOMES- A SYSTEMATIC REVIEW AND TAXONOMY OF PERFORMANCE-BASED HEALTH OUTCOMES AGREEMENTS BETWEEN HEALTH CARE PAYERS AND MANUFACTURERS

    May 1, 2009, 00:00

  • PCV15 EFFECT OF STATIN THERAPY ON RISK OF CORONARY DISEASE IN PRIMARY AND SECONDARY PREVENTION TRIALS- A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

    May 1, 2009, 00:00

  • PMH22 ECONOMIC EVALUATION OF AGOMELATINE FOR MAJOR DEPRESSIVE DISORDER IN SWEDEN

    May 1, 2009, 00:00

  • PIH27 THE IMPACT ON ADHERENCE AND FORMULARY PERFORMANCE METRICS OF ALLOWING MEMBERS TO CHOOSE EITHER MAIL OR RETAIL PHARMACY FOR RECEIVING 90-DAY SUPPLY MAINTENANCE MEDICATIONS

    May 1, 2009, 00:00

  • PMH76 PREDICTORS OF HIGHER HEALTH CARE EXPENDITURES IN PATIENTS WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER

    May 1, 2009, 00:00

  • PCV48 USING EXPERT ELICITATION TO INFORM ADOPTION AND RESEARCH DECISIONS FOR ENHANCED EXTERNAL COUNTERPULSATION IN ANGINA

    May 1, 2009, 00:00

  • PIN4 US HEPATITIS-C BURDEN ASSESSMENT FROM A TRANSMISSION MODEL

    May 1, 2009, 00:00

  • PHP44 WILLINGNESS TO PAY FOR PHARMACISTS DISPENSING SERVICE- A CROSS SECTIONAL PILOT STUDY IN THE STATE OF PENANG, MALAYSIA

    May 1, 2009, 00:00

  • PSY22 ECONOMIC EVALUATION OF RECOMBINANT FACTOR VIII PRODUCTS IN TREATMENT OF HAEMOPHILIA A. IN KOREA

    May 1, 2009, 00:00

  • PMH36 COMPARISON OF HOSPITALIZATIONS AND HEALTH CARE COSTS OF ELDERLY MAJOR DEPRESSIVE DISORDER (MDD) PATIENTS TREATED WITH ESCITALOPRAM, GENERIC SSRIS, OR SNRIS

    May 1, 2009, 00:00

  • PHP10 CHARACTERISTICS OF MEDICARE PART-D ENROLLEES WITH AND WITHOUT PRESCRIPTION DRUG COVERAGE GAP

    May 1, 2009, 00:00

  • PSY18 ECONOMIC EVALUATION OF AN INTERNET BASED WEIGHT MANAGEMENT PROGRAM

    May 1, 2009, 00:00

  • PGI19 REDUCING MEDICAL COSTS THROUGH PREVENTING LABORATORY ERRORS- AN EVALUATION OF BAYESIAN NETWORK MODEL IN DETECTING ERRORS OF LIVER ENZYME LAB VALUES

    May 1, 2009, 00:00

  • PMH71 OFF-LABEL PRESCRIPTION RATE OF ANTIDEPRESSANTS AMONG OFFICE BASED PHYSICIAN AND HOSPITAL OUTPATIENT PRACTICES DURING 2003-2005

    May 1, 2009, 00:00

  • PSY19 COST-EFFECTIVENESS COMPARISON ANALYSIS OF ANTI-TNF AGENTS WITH MULTIPLE INDICATIONS

    May 1, 2009, 00:00

  • PGI7 COST-EFFECTIVENESS ANALYSIS OF ADALIMUMAB VS. CERTOLIZUMAB MAINTENANCE THERAPIES FOR MODERATE TO SEVERE CROHNS DISEASE

    May 1, 2009, 00:00

  • PCV96 ASSOCIATIONS BETWEEN BASELINE LOW DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C) LEVELS AND TREATMENT INITIATION OF SELECTED STATINS IN A MANAGED CARE POPULATION

    May 1, 2009, 00:00

  • PGI13 RESPONSIVENESS TO CHANGE AND CLINICALLY RELEVANT IMPROVEMENTS OF THE SF-36 QUESTIONNAIRE IN SWEDISH PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE

    May 1, 2009, 00:00

  • PSS18 LINGUISTIC VALIDATION OF THE ATTENTION AND PERFORMANCE SELF-ASSESSMENT SCALE, APSA, FOR USE IN INTERNATIONAL STUDIES

    May 1, 2009, 00:00

  • CV4 ASPIRIN VERSUS CLOPIDOGREL IN COMBINATION WITH PROTONPUMP INHIBITORS FOR PREVENTION OF RECURRENT PEPTIC ULCER COMPLICATIONS IN PATIENTS WITH PREVIOUS GASTROINTESTINAL BLEEDING

    May 1, 2009, 00:00

  • PUK17 THE FDA DRAFT GUIDANCE ON PATIENT-REPORTED OUTCOMES CAN BE USED TO IMPROVE THE ESTIMATION OF UTILITIES. A CASE STUDY IN CHRONIC KIDNEY DISEASE

    May 1, 2009, 00:00

  • PHP72 PATIENT PRIVACY AND DATA CONFIDENTIALITY AND THE USE OF SECONDARY DATA

    May 1, 2009, 00:00

  • PSY31 REAL-WORLD USE OF DULOXETINE FOR LOW BACK PAIN

    May 1, 2009, 00:00

  • PSS5 A COST COMPARISON OF ADALIMUMAB AND ETANERCEPT FOR THE TREATMENT OF CHRONIC PLAQUE PSORIASIS IN THE UNITED KINGDOM

    May 1, 2009, 00:00

  • PSS2 DISTRIBUTION OF PATHOGENS ASSOCIATED WITH ACUTE OTITIS MEDIA- A SYSTEMATIC REVIEW OF THE LITERATURE

    May 1, 2009, 00:00

  • PHP77 MEXICAN POSTER PRESENTATIONS AT ISPOR MEETINGS- A QUALITY AND TENDENCY ASSESSMENT 2003-2008

    May 1, 2009, 00:00

  • PSS13 OUTCOMES OF CATARACT PATIENTS WITH ASTIGMATISM- IMPLANTATION OF TORIC VERSUS CONVENTIONAL MONOFOCAL INTRAOCULAR LENS

    May 1, 2009, 00:00

  • PCV93 CARDIOVASCULAR RISK (ACCORDING TO FRAGMINHAN) FOLLOW-UP OF A COHORT INSCRIBED IN THE DE TODO CORAZON (DTC) DISEASE MANAGEMENT PROGRAMME OF MUTUAL SER HMO IN COLOMBIA, 2004-2007

    May 1, 2009, 00:00

  • PMC58 TEST-RETEST RELIABILITY OF THE EQ-5D VISUAL ANALOG SCALE ACROSS POPULATIONS AND CONDITIONS

    May 1, 2009, 00:00

  • PMC36 THE POPULATION IMPACT OF CHEMOTHERAPY IN LATE-STAGE PROSTATE CANCER- A SIMULATION STUDY USING TAX327 AND SEER-MEDICARE DATA

    May 1, 2009, 00:00

  • PMS37 QUALITY OF LIFE AND COMPLIANCE IN GIRLS WITH ADOLESCENT IDIOPATHIC SCOLIOSIS

    May 1, 2009, 00:00

  • PCV46 COST-EFFECTIVENESS AND BUDGET IMPACT OF INTRODUCING FLUVASTATIN XL 80 MG INTO THE BRAZILIAN NATIONAL DRUG FORMULARY

    May 1, 2009, 00:00

  • PCV90 PHARMACEUTICAL SPENDING ON CHRONIC DISEASES IN CONSUMER DIRECTED HEALTH PLANS

    May 1, 2009, 00:00

  • PCV26 HEALTH CARE UTILIZATION AND RISK OF CARDIOVASCULAR DISEASE ASSOCIATED WITH METABOLIC SYNDROME

    May 1, 2009, 00:00

  • PDB3 EFFECTS OF SUSTAINED-RELEASE VERSUS IMMEDIATE-RELEASE GLIPIZIDES FOR TYPE-2 DIABETES MELLITUS- A SYSTEMATIC REVIEW OF 16 RANDOMIZED TRIALS

    May 1, 2009, 00:00

  • PRS12 ALLERGY IMMUNOTHERAPY CONFERS SIGNIFICANT HEALTH CARE COST SAVINGS WITHIN 3 MONTHS OF INITIATION- A MATCHED RETROSPECTIVE COHORT STUDY OF MEDICAID-ENROLLED CHILDREN NEWLY DIAGNOSED WITH ALLERGIC RHINITIS

    May 1, 2009, 00:00

  • PDB38 THE EFFECT OF WEIGHT CHANGES ON HEALTH-RELATED QUALITY OF LIFE AND WORK IMPAIRMENT IN PATIENTS WITH TYPE 2 DIABETES

    May 1, 2009, 00:00

  • PCV103 ASSOCIATION BETWEEN COPAYMENT AND ADHERENCE TO STATIN TREATMENT IN A VETERAN POPULATION- A RETROSPECTIVE ANALYSIS

    May 1, 2009, 00:00

  • PMS46 PHYSICAL ACTIVITY IN CANADIAN ADULTS WITH ARTHRITIS- A POPULATION-BASED STUDY

    May 1, 2009, 00:00

  • PDB62 THE IMPACT OF PHARMACISTS INTERVENTIONS ON OUTCOMES OF DIABETIC PATIENTS COMPARED TO USUAL CARE

    May 1, 2009, 00:00

  • PUK10 LONG-TERM COST EFFECTIVENESS OF SIROLIMUS REGIMEN COMPARED WITH CALCINEURIN INHIBITOR REGIMENS FOR IMMUNOSUPPRESSION AFTER RENAL TRANSPLANTATION IN KOREA

    May 1, 2009, 00:00

  • PMH25 COST-EFFECTIVENESS OF ESCITALOPRAM VERSUS VENLAFAXINE IN SECOND-LINE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) IN SWEDEN

    May 1, 2009, 00:00

  • PCV75 IMPACT OF MEDICATION ADHERENCE ON CARDIOVASCULAR DISEASE-RELATED HEALTH CARE COST AMONG PATIENTS TREATED WITH FIXED DOSE COMBINATION VERSUS MULTI-PILL COMBINATION THERAPIES AMONG DYSLIPIDEMIA PATIENTS IN A MANAGED CARE POPULATION

    May 1, 2009, 00:00

  • PRS21 THE WORKPLACE BURDEN OF SMOKING

    May 1, 2009, 00:00

  • PSY47 CROHNS DISEASE TREATMENT PARADIGM

    May 1, 2009, 00:00

  • PMC20 ESTIMATION OF HETEROGENOUS AVERAGE TREATMENT EFFECT OF BIOLOGIC DMARDS- PANEL DATA CORRELATED RANDOM COEFFICIENTS MODEL WITH POLYCHOTOMOUS ENDOGENOUS TREATMENT

    May 1, 2009, 00:00

  • PHP8 A COMPARISON OF POLICIES ON PAEDIATRIC DOSING GUIDELINES AND INDICATIONS BETWEEN THE UNITED STATES AND EUROPE

    May 1, 2009, 00:00

  • PMC34 TOO MUCH ADO ABOUT INSTRUMENTAL VARIABLE APPROACH- IS THE CURE WORSE THAN THE DISEASE?

    May 1, 2009, 00:00

  • PCN44 PHARMACOECONOMICAL ASPECT OF ONCOLOGICAL THERAPY

    May 1, 2009, 00:00

  • PCN38 COST-EFFECTIVENES ANALYSIS OF DOCETAXEL VERSUS STANDARD REGIMEN AS THE INDUCTION CHEMOTHERAPY OF LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA IN POLAND

    May 1, 2009, 00:00

  • PMS20 A COMPARISON OF DIFFERENT METHODS OF ESTIMATING FRACTURE RISK AND FRACTURE RISK REDUCTION IN COST-EFFECTIVENESS ANALYSES OF THE OSTEOPOROSIS TREATMENT BAZEDOXIFENE

    May 1, 2009, 00:00

  • MD2 RACIAL DISPARITIES IN ANTI-DEMENTIA MEDICATION, ANTIDEPRESSANT, AND ANTIPSYCHOTIC USE AMONG MEDICARE BENEFICIARIES WITH ALZHEIMERS DISEASE AND RELATED DEMENTIAS

    May 1, 2009, 00:00

  • PUK8 THE COST-EFFECTIVENESS OF PARICALCITOL VERSUS STANDARD TREATMENT FOR SECONDARY HYPERPARATHYROIDISM - MULTICOUNTRY PERSPECTIVES

    May 1, 2009, 00:00

  • PDB63 THE IMPACT OF A PPO PAY-FOR-PERFORMANCE PROGRAM ON DIABETIC PATIENTS

    May 1, 2009, 00:00

  • PIN26 COST MINIMIZATION ANALYSIS FOR GENERIC AND BRAND NAME ANTIBIOTICS

    May 1, 2009, 00:00

  • PND15 LITERATURE REVIEW ON THE GLOBAL COST OF MULTIPLE SCLEROSIS

    May 1, 2009, 00:00

  • PSY32 HEALTH CARE UTILIZATION AND FACTOR COST IN HEMOPHILIA

    May 1, 2009, 00:00

  • PHC8 REGIONAL DISPARITIES AND ECONOMIC OUTCOMES ASSOCIATED WITH MINIMALLY INVASIVE AND CONVENTIONAL SURGERIES OF THE CHEST, ABDOMEN, AND PELVIS

    May 1, 2009, 00:00

  • PRS20 THE DIRECT ECONOMIC IMPACT OF EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)- A REVIEW OF THE LITERATURE

    May 1, 2009, 00:00

  • PHP43 DEVELOPING A FRAMEWORK FOR THE INCLUSION OF PHARMACEUTICALS IN HEALTH INSURANCE BENEFIT PACKAGE, A COMPARATIVE STUDY ON IRANIAN SOCIAL SECURITY ORGANIZATION

    May 1, 2009, 00:00

  • PMH77 IMPACT OF THE BRAZILIAN PUBLIC MENTAL HEALTH POLICY ON SCHIZOPHRENIA HOSPITALIZATION- A 10-YEAR ANALYSIS

    May 1, 2009, 00:00

  • PIN43 THE IMPACT OF ADVERSE DRUG REACTIONS ASSOCIATED WITH ANTI-TUBERCULOSIS MEDICATIONS ON HEALTH-RELATED QUALITY OF LIFE- A LONGITUDINAL ANALYSIS

    May 1, 2009, 00:00

  • PMH42 IMPACT OF ALTERNATIVE DEFINITIONS OF MEDICATION COMPLIANCE ON FIRST YEAR TREATMENT COST FOR PATIENTS WITH SCHIZOPHRENIA

    May 1, 2009, 00:00

  • PCN76 REVISITING CHERNOBYL- THE LONG-RUN IMPACT OF THE NUCLEAR ACCIDENT ON LABOR MARKET OUTCOMES

    May 1, 2009, 00:00

  • PMC37 COMPARISON OF PROPENSITY SCORE MATCHING AND USE OF INVERSE PROBABILITY OF TREATMENT WEIGHTS

    May 1, 2009, 00:00

  • PGI20 CLINICAL OUTCOMES AND PATTERNS OF CARE IN PATIENTS WITH CHRONIC LIVER DISEASE, BRIDGING FIBROSIS, AND CIRRHOSIS- ADAPTABLE METHODOLOGIES FOR THE DESIGN, IMPLEMENTATION AND CONDUCT OF MULTI-NATIONAL, RETROSPECTIVE CHART REVIEW STUDIES

    May 1, 2009, 00:00

  • PCV71 COST-EFFECTIVENESS OF EZETIMIBE/SIMVASTATIN VERSUS SIMVASTATIN- WILL THE INCREASED RISK OF CANCER MAKE EZETIMIBE/SIMVASTATIN AN INAPPROPRIATE TREATMENT CHOICE?

    May 1, 2009, 00:00

  • PMS52 NSAIDS CONSUMPTION IN CROATIA- THE EFFECTS OF PRICING POLICY CHANGES

    May 1, 2009, 00:00

  • PHP85 REVIEW OF HTA RECOMMENDATIONS FOR DRUG THERAPIES IN POLAND ISSUED FROM SEPTEMBER 6, 2007 UNTIL OCTOBER 28, 2008 BY THE CONSULTATIVE COUNCIL (APPRAISAL COMMITTEE) OF AHTAPOL IN POLAND

    May 1, 2009, 00:00

  • PSY21 COST-EFFECTIVENESS OF PREGABALIN IN PATIENTS WITH FIBROMYALGIA- A MEXICAN PERSPECTIVE

    May 1, 2009, 00:00

  • PMH60 EFFECT OF BLACK-BOX WARNING ON TIME TO SWITCH FROM ANTIDEPRESSANTS TO ANTIPSYCHOTICS AMONG CHILDREN SUFFERING FROM DEPRESSIVE DISORDERS IN TEXAS

    May 1, 2009, 00:00

  • PMC51 TESTING THE ROLE OF TIME IN AFFECTING THE UNIDIMENSIONALITY IN EQ-5D USING THE 2002-2003 MEDICAL EXPENDITURE PANEL SURVEY (MEPS)- A FACETS MODEL APPROACH

    May 1, 2009, 00:00

  • PDB7 ADMINISTRATIVE CLAIMS ANALYSIS OF PATIENTS WITH TYPE-2 DIABETES INITIATING SITAGLIPTIN THERAPY

    May 1, 2009, 00:00

  • PIH3 SYSTEMATIC LITERATURE REVIEW OF THE GYNECARE PROLIFT, PELVIC FLOOR REPAIR SYSTEM TREATMENT OUTCOMES

    May 1, 2009, 00:00

  • PMH10 RISK OF INJURY IN ADULTS WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER

    May 1, 2009, 00:00

  • PCV56 COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE 150 MG FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN PATIENTS UNDERGOING TOTAL HIP OR KNEE ARTHROPLASTY THAT HAVE MODERATE IMPAIRMENT OF RENAL FUNCTION

    May 1, 2009, 00:00

  • PND11 COST-EFFECTIVENESS OF SCREENING AND TREATMENT OF ALZHEIMERS DISEASE WITH DONEPEZIL IN THE UNITED KINGDOM

    May 1, 2009, 00:00

  • PHP18 WASTED MEDICATION- HOW BIG IS THE PROBLEM?

    May 1, 2009, 00:00

  • PND27 THE IMPACT OF DIFFERENT STAGES OF MULTIPLE SCLEROSIS ON HEALTH UTILITIES- A SYSTEMATIC REVIEW OF THE LITERATURE

    May 1, 2009, 00:00

  • MD4 THE EFFECT OF MEDICARE PART D ON INAPPROPRIATE PSYCHOTROPIC MEDICATION USE IN THE ELDERLY

    May 1, 2009, 00:00

  • PMC19 COST-EFFECTIVENESS OF PREVENTIVE CARE AND MEDICINES- DO AGING DISEASES OFFSET SAVINGS FROM MORBIDITY REDUCTION?

    May 1, 2009, 00:00

  • PMC65 A NOVEL COMPARISON OF QUALITATIVE DATA SOURCES- CONTENT ANALYSIS OF SEMI - STRUCTURED PATIENT INTERVIEWS VERSUS WEBLOGS (BLOGS)

    May 1, 2009, 00:00

  • PCN95 STRUGGLING WITH EXPENSIVE NEW CANCER THERAPIES- A NATIONAL SURVEY OF ONCOLOGISTS IN THE UNITED STATES

    May 1, 2009, 00:00

  • PMC83 USE OF CONJOINT ANALYSIS IN HEALTH OUTCOMES RESEARCH- AN EXAMINATION OF THE LITERATURE

    May 1, 2009, 00:00

  • FD1 PREFERRED DRUG BENEFIT PLAN FOR CIVIL SERVANT MEDICAL BENEFIT SCHEME IN THAILAND- A CONJOINT ANALYSIS

    May 1, 2009, 00:00

  • PCV31 US BUDGET IMPACT OF INCREASING ASPIRIN USAGE FOR PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE

    May 1, 2009, 00:00

  • PMS43 IS THE HEALTH UTILITIES INDEX VALID AND RESPONSIVE IN ASSESSING PATIENTS WITH ANKYLOSING SPONDYLITIS?

    May 1, 2009, 00:00

  • PCN8 COMPARISON OF INFECTION-RELATED HOSPITALIZATION RISK AND ASSOCIATED COSTS AMONG PATIENTS RECEIVING SARGRAMOSTIM, FILGRASTIM, AND PEGFILGRASTIM FOR CHEMOTHERAPY-INDUCED NEUTROPENIA

    May 1, 2009, 00:00

  • PMH79 IDENTIFICATION OF TREATMENT RESISTANT DEPRESSION IN CLAIMS DATA- A COMPARISON OF METHODS

    May 1, 2009, 00:00

  • PCV81 MEASURING THE IMPACT OF SOCIO-DEMOGRAPHIC CHARACTERISTICS ON PATIENT PERSISTENCE IN CHRONIC MARKETS

    May 1, 2009, 00:00

  • PMH70 PHYSICIANS ATTITUDE TO PRESCRIBING ANTIDEPRESSANT THERAPY IN OLDER PATIENTS WITH DEPRESSION

    May 1, 2009, 00:00

  • PGI2 CHANGES IN PRESCRIPTIONS DISPENSED ON PROTON PUMP INHIBITORS (PPIS) FOLLOWING NEW RESTRICTIONS FOR REIMBURSEMENT-A NATIONWIDE NORWEGIAN PRESCRIPTION DATABASE STUDY

    May 1, 2009, 00:00

  • PMC43 INSTRUMENTAL VARIABLE APPROACH IN OUTCOMES RESEARCH

    May 1, 2009, 00:00

  • PMH68 IMPACT OF FAMILY STRUCTURE ON STIMULANT USE AMONG CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER

    May 1, 2009, 00:00

  • PCV101 A REVIEW OF TREATMENT PATTERNS OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION IN THREE EUROPEAN COUNTRIES

    May 1, 2009, 00:00

  • PCN18 ECONOMIC IMPACT OF SEVERE INFUSION REACTIONS IN PATIENTS WITH COLORECTAL CANCER TREATED WITH CETUXIMAB

    May 1, 2009, 00:00

  • PGI12 THE EFFECT OF A PRIOR AUTHORIZATION PROGRAM FOR PROTON-PUMP INHIBITORS ON MEDICATION PERSISTENCE AMONG THE ELDERLY

    May 1, 2009, 00:00

  • PGI18 EXAMINING PROTON PUMP INHIBITOR (PPI) TREATMENT PATTERNS AMONG PATIENTS WITH SELECTED UPPER GASTROINTESTINAL CONDITIONS

    May 1, 2009, 00:00

  • PMH38 THE ECONOMIC IMPACT OF GENERIC SWITCHING FOR PATIENTS WITH MAJOR DESPRESSIVE DISORDER (MDD) TREATED WITH ESCITALOPRAM OR A PATENTED SSRI

    May 1, 2009, 00:00

  • PIN46 EVALUATING SOCIETAL PREFERENCES FOR THE HUMAN PAPILLOMAVIRUS VACCINES USING DISCRETE CHOICE EXPERIMENT

    May 1, 2009, 00:00

  • PSS9 REDUCTION OF ACUTE OTITIS MEDIA IN CHILDREN- A COSTCONSEQUENCE ANALYSIS OF THE NEW 10-VALENT PNEUMOCOCCAL NON-TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN-D CONJUGATE VACCINE (PHID-CV) COMPARED WITH THE 7-VALENT PNEUMOCOCCAL VACCINE (PCV-7) ...

    May 1, 2009, 00:00

  • PMH15 COSTS OF DEMENTIA IN HUNGARY

    May 1, 2009, 00:00

  • PIH50 USE OF CATEGORY X AND D APIS DURING PREGNANCY- A COMPARATIVE, RETROSPECTIVE, CROSS-SECTIONAL STUDY USING NAMCS AND NHAMCS DATABASES

    May 1, 2009, 00:00

  • PIN20 COST-EFFECTIVENESS OF PNEUMOCOCCAL POLYSACCHARIDE VACCINATION IN ADULTS- A SYSTEMATIC REVIEW OF CONCLUSIONS AND ASSUMPTIONS

    May 1, 2009, 00:00

  • PND29 CANADIAN PATIENT SURVEY TO ASSESS PATIENTS PLIGHT TO MOVEMENT DISORDER DIAGNOSES AND BOTULINUM TOXIN TYPE-A (BONTA) TREATMENT - FINAL RESULTS

    May 1, 2009, 00:00

  • PMS27 COSTS OF PSORIATIC ARTHRITIS IN HUNGARY; RESULTS FROM A CROSS-SECTIONAL SURVEY

    May 1, 2009, 00:00

  • PCV107 SPECIFICITY OF ADMINISTRATIVE DATA FOR IDENTIFYING HEART FAILURE PATIENTS FOR HOSPITAL QUALITY PERFORMANCE INITIATIVES

    May 1, 2009, 00:00

  • PDB6 18 MONTH A1C AND WEIGHT OUTCOMES OF EXENATIDE THERAPY IN PATIENTS WITH TYPE-2 DIABETES IN A REAL-WORLD STUDY

    May 1, 2009, 00:00

  • PND6 COMPARISON OF COSTS FOR INTERFERON BETA 1-A AND NATALIZUMAB IN PATIENTS WITH MULTIPLE SCLEROSIS

    May 1, 2009, 00:00

  • CN3 ASSESSING THE MAJOR DRIVERS FOR THE INCREASED HEALTH CARE COSTS ASSOCIATED WITH COLORECTAL CANCER

    May 1, 2009, 00:00

  • UT2 ELICITING TIME TRADE-OFF AMOUNTS FOR HEALTH STATES IN HYPOTHETICAL INDIVIDUALS OF DIFFERENT AGES USING A DISCRETE CHOICE EXPERIMENT

    May 1, 2009, 00:00

  • PUK1 CHARACTERIZATION OF IMMUNOSUPPRESSIVE MEDICATION USE IN KIDNEY TRANSPLANTATIONS IN ACADEMIC MEDICAL CENTERS

    May 1, 2009, 00:00

  • PMS15 RELATIONSHIP BETWEEN SURGICAL INTERVENTION TYPE AND 30 DAYS MORTALITY OF ELDERLY FEMORAL NECK FRACTURE IN THE PRSENCE OF DIFFERENT CO-MORBIDITIES

    May 1, 2009, 00:00

  • PIH28 THE IMPACT OF MEDICARE SUPPLEMENT INSURANCE ON ACCESS, UTILIZATION, AND COST OF HEALTH CARE AND ON COMPLIANCE WITH RECOMMENDED PHARMACEUTICAL TREATMENT

    May 1, 2009, 00:00

  • PMS29 GOLIMUMAB SIGNIFICANTLY REDUCES TIME LOST FROM WORK FOR PATIENTS WITH RHEUMATOID ARTHRITIS- POOLED RESULTS FROM THREE PHASE 3 STUDIES

    May 1, 2009, 00:00

  • PIH35 DEVELOPMENT OF THE INJECTION PEN ASSESSMENT QUESTIONNAIRE (IPAQ) TO EVALUATE A NEW DEVICE TO ADMINISTER HUMAN GROWTH HORMONE (HGH)

    May 1, 2009, 00:00

  • PMS56 PHARMACY REFILL PATTERNS FOR SUBCUTANEOUS ANTI-TUMOR NECROSIS FACTOR AGENTS USED IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN A MANAGED CARE SETTING

    May 1, 2009, 00:00

  • PIH16 COST-EFFECTIVENESS ASSESSMENT OF LEVONORGESTREL INTRAUTERINE SYSTEM IN PATIENTS WITH IDIOPATHIC MENORRHAGIA IN A HONG KONG PUBLIC HOSPITAL

    May 1, 2009, 00:00

  • PMH8 GROWTH AND DIFFUSION OF ANTIPSYCHOTIC MEDICINES FOR LABELED AND OFF-LABELED USES, 1994-2007

    May 1, 2009, 00:00

  • PIN10 BUDGET IMPACT OF ANTIMALARIA DRUG FORMULARY DECISIONS- A RETROSPECTIVE ANALYSIS FROM A NIGERIAN TEACHING HOSPITAL

    May 1, 2009, 00:00

  • RA2 RISK OF DIABETES ASSOCIATED WITH THE USE OF ATYPICAL ANTIPSYCHOTICS IN CHILDREN AND ADOLESCENTS - A TEXAS MEDICAID STUDY

    May 1, 2009, 00:00

  • PIN40 MEASUREMENT OF SYMPTOMS AND IMPACT OF INFLUENZA- DEVELOPMENT OF THE SYMPTOM INTENSITY AND IMPACT OF INFLUENZA QUESTIONNAIRE (FLU-IIQ)

    May 1, 2009, 00:00

  • PIH12 COMPARISON OF YAZ TO SSRIS IN THE TREATMENT OF PREMENSTRUAL DYSPHRORIC DISORDER- COST-EFFECTIVENESS ANALYSIS

    May 1, 2009, 00:00

  • PCN88 LEVERAGING PATIENT-REPORTED OUTCOMES TO DEFINE FATIGUE IN CANCER

    May 1, 2009, 00:00

  • PRS4 DRUG UTILIZATION AND SPENDING TRENDS FOR ANTI-ASTHMATIC AGENTS IN US MEDICAID PROGRAM FROM 1991 TO 2007

    May 1, 2009, 00:00

  • PMS1 INCREASED STANDARDIZED MORTALITY RATIO IN WORKERS WITH PERMANENT OCCUPATIONAL DISABILITY OF LOWER LIMB- A FOLLOW-UP STUDY OF 21 YEARS

    May 1, 2009, 00:00

  • PMC69 MULTITRAIT-MULTIMETHOD ANALYSIS OF THREE GENERIC PREFERENCE-BASED HEALTH-RELATED QUALITY OF LIFE MEASURES IN THE NATIONAL HEALTH MEASUREMENT STUDY

    May 1, 2009, 00:00

  • PMH44 IMPACT OF REJECTED CLAIMS ON PERSISTENCE TO SECOND GENERATION ANTI-PSYCHOTIC MEDICATIONS

    May 1, 2009, 00:00

  • PRS26 AN ECONOMIC EVALUATION OF GRAZAX FOR THE TREATMENT OF GRASS POLLEN INDUCED RHINOCONJUNCTIVITIS IN CHILDREN

    May 1, 2009, 00:00

  • PDB48 GEOGRAPHIC VARIATION IN MEDICATION ADHERENCE

    May 1, 2009, 00:00

  • PIN3 ECONOMIC ANALYSIS OF MICAFUNGIN VERSUS CASPOFUNGIN THERAPY FOR THE TREATMENT OF CANDIDEMIA AND PNEUMONIA INFECTIONS

    May 1, 2009, 00:00

  • PCV54 COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE 150 MG FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN PATIENTS AGED OVER 75 YEARS UNDERGOING TOTAL HIP OR KNEE ARTHROPLASTY

    May 1, 2009, 00:00

  • PSY2 HOW WELL DOES BODY MASS INDEX PREDICT WAIST CIRCUMFERENCE FOR PATIENTS WITH METABOLIC SYNDROME?

    May 1, 2009, 00:00

  • PCV25 SMOKING AND STROKE IN THE CHINESE SMOKING POPULATION

    May 1, 2009, 00:00

  • PMS53 DISPARITIES IN MAJOR JOINT REPLACEMENT SURGERY AMONG ENROLLEES WITH AARP MEDICARE SUPPLEMENT INSURANCE

    May 1, 2009, 00:00

  • PSY1 OXYCODONE-RELATED FATALITIES IN WEST VIRGINIA

    May 1, 2009, 00:00

  • PCN98 IMPACT OF RECENT ERYTHROPOIESIS-STIMULATING AGENT (ESA) POLICY CHANGES ON DOSING PATTERNS IN CANCER CHEMOTHERAPY PATIENTS

    May 1, 2009, 00:00

  • PHP66 EVALUATION OF THE FIRST-YEAR OPERATION OF KOREAN POSITIVE LIST SYSTEM FOR PHARMACEUTICAL REIMBURSEMENT

    May 1, 2009, 00:00

  • RR1 QUARTERLY ASSESSMENT OF SHORT ACTING -AGONIST USE AS A PREDICTOR OF SUBSEQUENT HEALTH CARE SERVICES USE FOR ASTHMATICS IN THE U.S.

    May 1, 2009, 00:00

  • PRS45 SMOKING-ATTRIBUTABLE BURDEN OF FOUR TOBACCO-RELATED DISEASES IN COLOMBIA IN 2007

    May 1, 2009, 00:00

  • PRS47 DATA ANALYSIS TECHNIQUES APPLIED TO DISCOVER TRENDS AND PATTERNS IN PEDIATRIC ASTHMA

    May 1, 2009, 00:00

  • PGI3 RISK OF UPPER GASTROINTESTINAL ADVERSE EVENTS AND THE EFFECT OF ACID-SUPPRESSIVE THERAPY IN PATIENTS RECEIVING ACETYLSALICYLIC ACID FOR CARDIOVASCULAR RISK MANAGEMENT

    May 1, 2009, 00:00

  • PCV39 COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE FOR THE PRIMARY PREVENTION OF VENOUS THROMBOEMBOLISM IN TOTAL HIP AND KNEE REPLACEMENT IN PORTUGAL

    May 1, 2009, 00:00

  • PIN49 NEW ANTIFUNGAL MEDICATION IMPACT ON MARKET SHARE AND UTILIZATION OF TRADITIONAL AGENTS IN A SINGLE HEALTH CARE SYSTEM

    May 1, 2009, 00:00

  • PSY28 ESTIMATE COSTS OF COMORBIDITES IN OVERWEIGHT AND OBESE MEXICAN CHILDREN AGED BETWEEN FIVE AND ELEVEN YEARS UNTIL DEATH

    May 1, 2009, 00:00

  • PMC26 USE OF HOSPITAL ELECTRONIC MEDICAL RECORD DATA TO DEFINE SEVERE SEPSIS, THE TIMING OF ORGAN DYSFUNCTION AND SOURCE OF INFECTION

    May 1, 2009, 00:00

  • PIN7 EXPLORING CELLULITIS- WHO GETS IT AND HOW SERIOUS IS IT?

    May 1, 2009, 00:00

  • PCN64 THE ECONOMIC BURDEN ASSOCIATED WITH METASTATIC COLORECTAL CANCER

    May 1, 2009, 00:00

  • PRS23 COST AND RESOURCE UTILIZATION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) OR WINTER UNSPECIFIED BRONCHIOLITIS OR PNEUMONIA (UBP) HOSPITALIZATIONS DURING THE FIRST YEAR OF LIFE AMONG LATE PRETERM AND FULL-TERM INFANTS

    May 1, 2009, 00:00

  • PSY39 LINGUISTIC VALIDATION OF THE LUPUS QOL QUESTIONNAIRE INTO 13 LANGUAGES

    May 1, 2009, 00:00

  • PMC3 USING FRONTIER ANALYSIS TO OPTIMIZE THE OVERALL LIFE YEARS GAINED IN VACCINATION POLICY OF INFECTIOUS DISEASES

    May 1, 2009, 00:00

  • PMC11 GROWTH, CHARACTERISTICS AND QUALITY OF THE COST-UTILITY ANALYSIS LITERATURE THROUGH 2006

    May 1, 2009, 00:00

  • PCN65 COST OF FIRST LINE METASTATIC COLON CANCER CHEMOTHERAPIES IN HUNGARY

    May 1, 2009, 00:00

  • PCV4 THE ASSOCIATION OF CO-MEDICATIONS AND CO-MORBIDITIES AND RISK OF DEMENTIA, IN PATIENTS WITH CHRONIC HEART FAILURE

    May 1, 2009, 00:00

  • PHP50 INCREMENTAL SICK LEAVE COSTS AND LOST TIME AMONG EMPLOYEES WITH PSYCHIATRIC AND MEDICAL CONDITIONS

    May 1, 2009, 00:00

  • PSS3 USING 'NUMBER NEEDED TO TREAT' TO HELP CONCEPTUALIZE THE MAGNITUDE OF BENEFIT AND RISK OF TNF INHIBITORS FOR PATIENTS WITH SEVERE PSORIASIS

    May 1, 2009, 00:00

  • PIH19 EXPANDED NEWBORN SCREENING IN TEXAS- A COST-EFFECTIVENESS ANALYSIS USING MARKOV MODELING

    May 1, 2009, 00:00

  • PHP94 WHEN COMPARATIVE EVIDENCE IS UNCERTAIN- USE OF QUANTITATIVE CONSENSUS METHODS TO FILL IN GAPS

    May 1, 2009, 00:00

  • PHP61 INFLUENCE OF HEALTH-RELATED QUALITY OF LIFE ON HEALTH SERVICE UTILIZATION IN ADDITION TO SOCIO-DEMOGRAPHIC AND MORBIDITY VARIABLES AMONG PRIMARY CARE PATIENTS IN CHINA

    May 1, 2009, 00:00

  • PRS6 ESTIMATION OF QUALITY-ADJUSTED LIFE EXPECTANCY AND LOSS OF UTILITY IN PATIENTS UNDER PROLONGED MECHANICAL VENTILATION

    May 1, 2009, 00:00

  • DU2 RACIAL DIAPARITIES AND BARRIER TO DRUG UTILIZATION IN PATIENTS WITH DIABETES IN THE UNITED STATES

    May 1, 2009, 00:00

  • PMH55 DIFFICULT TO SWALLOW- PATIENT PREFERENCES REGARDING ALTERNATIVE VALPROATE PHARMACEUTICAL FORMULATIONS

    May 1, 2009, 00:00

  • PMS45 EXTENSION FROM INPATIENTS TO OUTPATIENTS- PERFORMANCE OF THE OXFORD KNEE SCORE IN MEASURING HEALTH OUTCOMES IN PATIENTS WITH KNEE OSTEOARTHRITIS

    May 1, 2009, 00:00

  • PMC45 EXTENDING RANDOM EFFECT MODELS TO CENSORED COST DATA

    May 1, 2009, 00:00

  • PHP89 APPLES AND ORANGES? COMPARATIVE EFFECTIVENESS IN THE UNITED STATES AND OTHER COUNTRIES

    May 1, 2009, 00:00

  • PCN108 IMPACT OF NEW DRUGS AND BIOLOGICALS ON TREATMENT AND COSTS FOR COLORECTAL CANCER

    May 1, 2009, 00:00

  • PHC5 CHOICE OF HEMOSTATIC AGENT AND HOSPITAL LENGTH OF STAY IN CARDIOVASCULAR SURGERY

    May 1, 2009, 00:00

  • PDB61 HEALTH CARE COSTS AND UTILIZATION ASSOCIATED WITH TREATMENT MODIFICATION IN TYPE-2 DIABETES MELLITUS (T2DM) PATIENTS TAKING ORAL ANTI-DIABETIC DRUGS (OADS)

    May 1, 2009, 00:00

  • PCN103 SCREENING MAMMOGRAPHY TRENDS AMONG WOMEN IN A FEE-FOR-SERVICE MEDICAID POPULATION

    May 1, 2009, 00:00

  • PCN60 COSTS OF CARE FOR ELDERLY METASTATIC PROSTATE CANCER PATIENTS OVER TIME

    May 1, 2009, 00:00

  • PSY10 PREVALENCE OF METABOLIC SYNDROME AND DIFFERENCES IN HEALTH HABITS AMONG SUFFERERS AMONG U.S. ETHNIC GROUPS

    May 1, 2009, 00:00

  • PCN112 OFF-LABEL USE OF ONCOLOGY DRUGS IN A COMMUNITY ONCOLOGY EMR DATABASE

    May 1, 2009, 00:00

  • PSS21 DISEASE BURDEN AND PRODUCTIVITY LOSS IN A CANADIAN ONLINE SURVEY POPULATION OF INDIVIDUALS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS

    May 1, 2009, 00:00

  • PHP51 DOES IMPROVING QUALITY OF CARE SAVE MONEY? ANALYSIS OF HEALTH CARE EFFECTIVENESS DATA AND INFORMATION SET (HEDIS) MEASURES

    May 1, 2009, 00:00

  • PND39 ECONOMIC IMPACT OF GENERIC ENTRY OF TOPIRAMATE IN THE G4 EUROPEAN COUNTRIES

    May 1, 2009, 00:00

  • PCN71 COST-EFFECTIVENESS (CE) ANALYSIS OF ERBB2-TARGETED THERAPIES IN WOMEN WITH TRASTUZUMAB (TZ)-REFRACTORY ERBB2 METASTATIC BREAST CANCER (MBC) AND LIMITED EXPOSURE TO PRIOR CHEMOTHERAPY (CT)

    May 1, 2009, 00:00

  • PCN9 SYSTEMATIC LITERATURE REVIEW TO ADDRESS BREAST CANCER ISSUES IN LOW-AND MIDDLE-INCOMES COUNTRIES FROM 1990-2008

    May 1, 2009, 00:00

  • PHP46 EVALUATING COST DIFFERENCES AMONG OPERATIONAL TEAMS SUPPORTING THE INDIANA HEALTH INFORMATION EXCHANGE

    May 1, 2009, 00:00

  • PCV98 ADHERENCE TO MAINTENANCE MEDICATIONS BY DAYS SUPPLY AND DISTRIBUTION CHANNEL

    May 1, 2009, 00:00

  • PMH52 EVALUATING CENTRAL NERVOUS SYSTEM DRUG LABELS FOR PATIENT-REPORTED OUTCOMES CLAIMS

    May 1, 2009, 00:00

  • PMC6 META-REGRESSION AS A METHOD OF IDENTIFICATION OF THE CAUSES OF HETEROGENEITY BETWEEN STUDIES ON THE EXAMPLE OF RELATIONSHIP BETWEEN SURROGATES AND CLINICALLY IMPORTANT ENDPOINTS IN TYPE-2 DIABETES MELLITUS

    May 1, 2009, 00:00

  • PCV33 A LIFE-LONG COST-EFFECTIVENESS MARKOV MODEL COMPARING HIGH-DOSE VERSUS STANDARD DOSE STATIN THERAPY IN ACUTE CORONARY SYNDROME PATIENTS

    May 1, 2009, 00:00

  • PDB39 DEVELOPMENT OF A VALUATION FUNCTION FOR A DIABETESSPECIFIC PREFERENCE-BASED MEASURE OF HEALTH BASED ON THE MULTI-ATTRIBUTE UTILITY THEORY

    May 1, 2009, 00:00

  • PMC82 PSYCHOMETRIC PROPERTIES OF FOUR KISWAHILI TRANSLATED DISEASE SPECIFIC PATIENT REPORTED OUTCOME MEASURES

    May 1, 2009, 00:00

  • PCV21 PREVALENCE, AWARENESS, AND MANAGEMENT OF HYPERTENSION, DYSLIPIDEMIA, AND DIABETES AMONG UNINSURED AND INSURED ADULTS IN THE UNITED STATES

    May 1, 2009, 00:00

  • PHP62 THE PRELIMINARY IMPACT OF HOSPITAL GLOBAL BUDGETING ON THE QUALITY OF CARE

    May 1, 2009, 00:00

  • PMC14 DETERMINING COSTS OF CONCOMITANT MEDICATIONS IN RANDOMIZED CLINICAL TRIALS- A CASE STUDY

    May 1, 2009, 00:00

  • PCV78 INTERVENTIONS TO IMPROVE MEDICATION COMPLIANCE IN HYPERTENSION- QUALITATIVE AND QUANTITATIVE SYSTEMATIC REVIEW

    May 1, 2009, 00:00

  • PMC27 VARIATION IN ICD-9 DIAGNOSIS CODING WITHIN AND ACROSS HEALTH SYSTEMS

    May 1, 2009, 00:00

  • PCV108 USE OF RENIN SYSTEM AGENTS AMONG HYPERTENSION PATIENTS WITH RENAL DISEASE IN A MANAED CARE SETTING

    May 1, 2009, 00:00

  • PCN12 TIMING OF PHYSICIAN VISITS AND THE IMPACT ON SURVIVAL AMONG SEER-MEDICARE PATIENTS WITH STAGE IV PROSTATE CANCER

    May 1, 2009, 00:00

  • PMC2 LONGITUDINAL DATA EXPLORATION WITH STACKED CUMULATIVE PERCENT PLOTS FOR CATEGORICAL DATA

    May 1, 2009, 00:00

  • PHC6 SUBJECTS SUFFERING FROM HALITOSIS- IMPACTS OF THE TREATMENT

    May 1, 2009, 00:00

  • PGI4 NUMBER-NEEDED-TO-TREAT (NNT) ANALYSIS- REMISSION RATES FOR ADALIMUMAB VS. INFLIXIMAB IN CROHNS DISEASE

    May 1, 2009, 00:00

  • PCN24 THE ECONOMIC IMPLICATIONS OF RASBURICASE TREATMENT IN ADULT TUMOR LYSIS SYNDROME PATIENTS

    May 1, 2009, 00:00

  • PUK7 HOSPITAL DISCHARGE COST AND LENGTH OF STAY OF PERITONEAL DIALYSIS AND HEMODIALYSIS

    May 1, 2009, 00:00

  • PDB40 THE IMPACT OF FREQUENCY AND SEVERITY OF SELF-REPORTED HYPOGLYCEMIA ON QUALITY OF LIFE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TREATED WITH ORAL ANTI-HYPERGLYCEMIC AGENTS

    May 1, 2009, 00:00

  • PMS10 DOSING PATTERNS FOR RHEUMATOID ARTHRITIS PATIENTS T REATED WITH ABATACEPT OR INFLIXIMAB

    May 1, 2009, 00:00

  • PSY24 THE IMPACT OF OBESITY ON MEDICAL EXPENDITURE AND HEALTH RELATED QUALITY OF LIFE

    May 1, 2009, 00:00

  • PRS42 CURRENT PATTERNS OF FIXED AND FREE LABA/ICS COMBINATION USAGE IN ASTHMA SHI PATIENTS IN GERMANY

    May 1, 2009, 00:00

  • PMS57 PRIMARY CARE VISITS IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING INTRAVENOUS VERSUS SUBCUTAENOUS BIOLOGICS- A RETROSPECTIVE CLAIMS DATABASE STUDY

    May 1, 2009, 00:00

  • PIN13 COMPARATIVE COST-EFFICACY ANALYSIS OF DARUNAVIR/R FOR FIRST-LINE TREATMENT OF HIV INFECTION IN THE UNITED STATES

    May 1, 2009, 00:00

  • PCV30 THE ASSOCIATION OF ASPIRIN USE ON RISK OF HOSPITALIZATION IN CHF PATIENTS TAKING ACE INHIBITORS- A RETROSPECTIVE ANALYSIS OF A NATIONAL COHORT OF VETERANS

    May 1, 2009, 00:00

  • PRS3 COMPARATIVE EFFECTIVENESS OF IPRATROPIUM IN COPD PATIENTS

    May 1, 2009, 00:00

  • PMC81 ELECTRONIC PATIENT REPORTED OUTCOMES- FOLLOWING FDA GUIDANCE FROM A VENDOR PERSPECTIVE

    May 1, 2009, 00:00

  • PND4 RATE OF DISEASE PROGRESSION AMONG PATIENTS WITH PARKINSONS DISEASE IN SINGAPORE

    May 1, 2009, 00:00

  • PND33 EPIDEMIOLOGIC CHARACTERISTICS AND HEALTH RESOURCE USE IN A MULTIPLE SCLEROSIS CENTER IN SAO PAULO, BRAZIL

    May 1, 2009, 00:00

  • PRS15 SIMULATING COST-EFFECTIVENESS OF STEPPED CARE VERSUS REPEAT CARE IN SMOKING CESSATION

    May 1, 2009, 00:00

  • PMH49 ASSESSMENT OF TYPE 2 DIABETES MELLITUS PATIENTS WITH AND WITHOUT SYMPTOMS OF ADHD- PATIENT CHARACTERISTICS AND RESOURCE UTILIZATION DATA FROM AN INTERNET-BASED SURVEY

    May 1, 2009, 00:00

  • PMH45 THE ASSOCIATION OF COPAY BURDEN AND MEDICATION ADHERENCE AMONG PATIENTS WITH SCHIZOPHRENIA

    May 1, 2009, 00:00

  • MO1 IMPACT OF INCLUDING CARDIOVASCULAR AND RESPIRATORY OUTCOMES ON ESTIMATES OF CLINICAL AND ECONOMIC BENEFITS OF INFLUENZA VACCINATION IN THE U.S. ELDERLY POPULATION

    May 1, 2009, 00:00

  • PHP63 USE OF READY-TO-USE (RTU) VERSUS CUSTOMIZED NUTRITION (CNF) FORMULATIONS AS A TOTAL PARENTERAL NUTRITION (TPN) ALTERNATIVE IN MEXICAN PUBLIC HEALTH CARE SYSTEM. A PHARMACOECONOMIC APPROACH

    May 1, 2009, 00:00

  • PIN9 INCREASING THE AVAILABILITY OF ATAZANAVIR IN THE MINISTRY OF HEALTH (MOH) PUBLIC INSTITUTIONS IN MEXICO- A BUDGET IMPACT ANALYSIS

    May 1, 2009, 00:00

  • MS2 COMBINING THE SF-36 PHYSICAL FUNCTION SCALE AND THE HEALTH ASSESSMENT QUESTIONNAIRE TO IMPROVE MEASUREMENT OF PHYSICAL FUNCTION RHEUMATOID ARTHRITIS (RA)- RESULTS- FROM THE PREMIER STUDY

    May 1, 2009, 00:00

  • PDB50 STATUS OF DIABETES CONTROL AMONG COMMUNITY PHARMACY USERS WITH DIABETES- AN ANALYSIS OF THE MEDICAL EXPENDITURE PANEL SURVEY

    May 1, 2009, 00:00

  • PMH33 ECONOMIC IMPLICATION OF DOSE ESCALATION IN DEPRESSED PATIENTS TREATED WITH ESCITALOPRAM OR VENLAFAXINE XR

    May 1, 2009, 00:00

  • PMS7 A 2-YEAR EVALUATION OF INFLIXIMABS EFFECTIVENESS IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN ACTUAL PRACTICE

    May 1, 2009, 00:00

  • PMH3 DEPRESSION- ETHNIC DIFFERENCES IN PREVALENCE, DIAGNOSIS, AND SYMPTOMS

    May 1, 2009, 00:00

  • PHP17 CONTENT ANALYSIS OF OFF-LABEL DRUG USE- REPORTING PRINT MEDIA COVERAGE

    May 1, 2009, 00:00

  • PMH40 UNINTENDED CONSEQUENCES OF CURRENT ANTIDEPRESSANT USE IN A GERIATRIC POPULATION- DRUG-DRUG INTERACTIONS AND THEIR IMPLICATIONS FOR ADHERENCE

    May 1, 2009, 00:00

  • PSS14 HEALTH RESOURCE USE DURING STAPLE REMOVAL FOLLOWING GRAFT FIXATION

    May 1, 2009, 00:00

  • PMS28 THE COSTS OF NON-VERTEBRAL OSTEOPOROTIC FRACTURES IN THE UNITED STATES

    May 1, 2009, 00:00

  • PHP78 THE STATUS QUO OF THE USAGE OF CHINESE VERSIONS OF GENERIC HEALTH-RELATED QUALITY OF LIFE INSTRUMENTS

    May 1, 2009, 00:00

  • PMC77 DEVELOPMENT AND VALIDATION OF AN E-PRO TEMPLATE ADMINISTERED VIA A WEB-BASED INTERFACE

    May 1, 2009, 00:00

  • PUK15 QUALITY OF LIFE IN A RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED STUDY OF OXYBUTYNIN CHLORIDE TOPICAL GEL TREATMENT OF PATIENTS WITH OVERACTIVE BLADDER

    May 1, 2009, 00:00

  • PUK19 IMPACT OF SOLIFENACIN ON SYMPTOM BOTHER, HEALTH-RELATED QUALITY OF LIFE, WORK PRODUCTIVITY, TREATMENT SATISFACTION, AND SYMPTOMS IN PATIENTS WITH OVERACTIVE BLADDER- RESULTS FROM VIBRANT

    May 1, 2009, 00:00

  • PCV16 RISK OF RE-BLOCKING AN ARTERY AFTER A TREATMENT AS A FACTOR OF EPISODE GROUPING

    May 1, 2009, 00:00

  • PND35 SOCIOECONOMIC FACTORS OF INSOMNIA PRESCRIPTION IN A NATIONAL DATABASE

    May 1, 2009, 00:00

  • PMC74 QUALITY-ADJUSTED LIFE YEARS SAVED BY PREVENTION OF HEAD INJURY THROUGH ENFORCEMENT OF HELMET LAW

    May 1, 2009, 00:00

  • PIN24 ECONOMIC ANALYSIS OF PNEUMOCOCCAL VACCINATION FOR THE ELDERLY IN TAIWAN

    May 1, 2009, 00:00

  • PMH65 EFFECT OF HEALTH INSURANCE COVERAGE AND DEPRESSION ON PRESCRIPTION MEDICATION USE IN PATIENTS WITH CHRONIC MEDICAL DISORDERS

    May 1, 2009, 00:00

  • DB4 COST OF DIABETIC-RELATED COMPLICATIONS AND CARDIOVASCULAR EVENTS BY TYPE OF EVENT AND SETTING ANNUALLY FOR THE FIRST THREE YEARS FOLLOWING ITS ONSET

    May 1, 2009, 00:00

  • PDB45 SATISFACTION WITH DIABETES TREATMENTS- IMPACTS ON PATIENT HEALTH-RELATED QUALITY OF LIFE AND PRODUCTIVITY

    May 1, 2009, 00:00

  • PMC73 EVALUATION OF GLP-1 PRODUCT ATTRIBUTES IN TREATING PEOPLE WITH TYPE-2 DIABETES IN US- COMPARING TIME-TRADEOFF AND WILLINGNESS-TO-PAY METHODOLOGIES

    May 1, 2009, 00:00

  • PMS44 VALIDATION OF THE MULTI-ATTRIBUTE HEALTH UTILITY (MAHU) DERIVED FROM A COMPUTER ADAPTIVE INSTRUMENT, CAT-5D-QOL, IN OSTEOARTHRITIS

    May 1, 2009, 00:00

  • PCV43 WHICH PUBLIC POLICY IS MORE COST-EFFECTIVE IN REDUCING CARDIAC DEATHS- INCREASED TAXES OR SMOKING BANS?

    May 1, 2009, 00:00

  • PRS7 IMPACT OF STATIN THERAPY ON ASTHMA-RELATED EVENT COSTS IN ADULT ASTHMA PATIENTS

    May 1, 2009, 00:00

  • PHP9 THE IMPACT OF LEGISLATION AND PRICING ON GENERIC DRUG UTILIZATION- AN ANALYSIS OF 26 COUNTRIES

    May 1, 2009, 00:00

  • PMH23 PREGABALIN FOR THE TREATMENT OF GENERALIZED ANXIETY DISORDERS (GAD) - A COST-EFFECTIVENESS CASE STUDY OF MEXICO

    May 1, 2009, 00:00

  • PIN36 THE ECONOMIC IMPACT OF MARAVIROC FOR ANTIRETROVIRAL TREATMENT-EXPERIENCED HIV-INFECTED INDIVIDUALS IN MEXICO

    May 1, 2009, 00:00

  • PCN43 THE COST-EFFECTIVENESS OF HUMAN PAPILLOMAVIRUS DNA TESTING FOR CERVICAL CANCER- A SYSTEMATIC REVIEW OF THE LITERATURE

    May 1, 2009, 00:00

  • PCV2 UNDERSTANDING PATIENTS DIAGNOSED WITH ATHEROSCLEROSIS AND THEIR DIAGNOSIS AND TREATMENT PATTERNS

    May 1, 2009, 00:00

  • PMC55 IMPACT OF THE FDA DRAFT GUIDANCE ON PATIENT REPORTED OUTCOMES (PRO) LABEL CLAIMS FOR APPROVED DRUG PRODUCTS IN THE US- HAS IT MADE A DIFFERENCE?

    May 1, 2009, 00:00

  • PCN101 BREAST CANCER SCREENING OR DIAGNOSTIC PROCEDURES IN POSTMENOPAUSAL WOMEN INITIATING OSTEOPOROSIS MEDICATIONS

    May 1, 2009, 00:00

  • PIH9 A SIMULATION MODELING OF THE EFFECT OF DOSING SCHEDULE ON THE BENEFIT AND COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINATION IN CANADA

    May 1, 2009, 00:00

  • PDB25 USE OF GENERALIZED LINEAR MODEL TO FIND THE RELATIONSHIP BETWEEN DIAGNOSIS AND THE COST OF DIABETIC OUTPATIENTS

    May 1, 2009, 00:00

  • PSY4 THE USE OF THE HEMOPHILIA AND THROMBOSIS RESEARCH SOCIETY (HTRS) REGISTRY DATA TO UNDERSTAND DIFFERENCES IN RECOMBINANT FACTOR VIIA (RFVIIA) DOSING AND CLINICAL OUTCOMES FOR SPECIFIC JOINT HEMORRHAGES IN HEMOPHILIA

    May 1, 2009, 00:00

  • PCN83 A MULTINATIONAL STUDY OF PATIENT PREFERENCE VALUES FOR HEALTH STATES FOR CHRONIC MYELOGENOUS LEUKEMIA

    May 1, 2009, 00:00

  • PCASE3 HTA PROCEDURES IN DRUG REIMBURSEMENT PROCESS IN POLAND. EVOLUTION OF RECOGNITION THE ROLE OF AGENCY OF HEALTH TECHNOLOGY ASSESSMENT (AHTAPOL) BY POLICY MAKERS

    May 1, 2009, 00:00

  • PCV47 COST-EFFECTIVENESS OF ADD-ON EARLY STRESS MYOCARDIAL PERFUSION IMAGING FOR ASIAN PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT WITH CHEST PAIN BUT NON-DIAGNOSTIC ELECTROCARDIOGRAPHY-THE ACUTE CHEST PAIN TREATMENT EVALUATION STUDY ( ...

    May 1, 2009, 00:00

  • PIH52 TARGETED COMMUNITY OUTREACH REDUCES OUT-OF-POCKET PRESCRIPTION DRUG COSTS OF MEDICARE PART D BENEFICIARIES

    May 1, 2009, 00:00

  • PCV61 MEDICAL EXPENDITURES ATTRIBUTABLE TO CORONARY ARTERY DISEASE IN THE UNITED STATES

    May 1, 2009, 00:00

  • PSY8 IMPORTANCE OF ROUTINE URINE DRUG TESTING IN THE CHRONIC PAIN PATIENT POPULATION

    May 1, 2009, 00:00

  • PCN97 PHYSICIAN REFERRAL PATTERNS AMONG ELDERLY PATIENTS WITH STAGE IV PROSTATE CANCER (PCA)- AN ANALYSIS USING SEERMEDICARE DATA

    May 1, 2009, 00:00

  • PDB41 THE HANDLING OF GLUCOSE MONITORING AND INSULIN TREATMENT (HAGLUMIT) QUESTIONNAIRE CAPTURES HANDLING DIFFERENCES BETWEEN DIFFERENT SITUATIONS AND SYSTEMS FOR MONITORING BLOOD GLUCOSE IN DIABETES

    May 1, 2009, 00:00

  • PIN42 ANALYZING INPATIENT DATA FOR HEPATITIS PATIENTS

    May 1, 2009, 00:00

  • PM3 USE OF PHARMACOGENETIC TESTING TO DETERMINE ADJUVANT HORMONAL THERAPY CHOICE IN EARLY STAGE BREAST CANCER PATIENTS- A VALUE OF INFORMATION ANALYSIS

    May 1, 2009, 00:00

  • PMC41 COMPARISON OF ANALYTIC APPROACHES TO ESTIMATE INCREMENTAL EXPENDITURES- A CASE OF OTITIS MEDIA AMONG CHILDREN IN THE UNITED STATES

    May 1, 2009, 00:00

  • PRS25 THE FINANCIAL IMPACT OF COMPUTER SYSTEMS-BASED APPROACHES TO REDUCING REPEAT DRUG EXPOSURE IN PATIENTS WITH KNOWN DRUG ALLERGIES

    May 1, 2009, 00:00

  • HM1 EFFICIENCY AND ECONOMIC BENEFITS ASSOCIATED WITH THE USE OF A PAYER-BASED ELECTRONIC HEALTH RECORD IN AN EMERGENCY DEPARTMENT AMONG A HEALTH INSURED POPULATION

    May 1, 2009, 00:00

  • PDB46 CONTRIBUTIONS OF AND RELATIONSHIP BETWEEN EXPECTATIONS ABOUT AND EXPERIENCES WITH INSULIN THERAPY TO TREATMENT SATISFACTION IN INSULIN-NAVE PATIENTS WITH TYPE-2 DIABETES

    May 1, 2009, 00:00

  • QL1 COMPARISON BETWEEN THE EQ-5D AND THE SEVEN DERIVED HEALTH UTILITIES IN STROKE PATIENTS USING A NATIONAL REPRESENTATIVE SAMPLE IN THE UNITED STATES

    May 1, 2009, 00:00

  • PIN39 ASSESSING DISEASE BURDEN FOR MEASLES USING A CLINICAL AND HEALTH OUTCOMES APPROACH- A FOCUS ON LOWER-INCOME COUNTRIES

    May 1, 2009, 00:00

  • PRS14 ANALYSIS OF OUTCOMES AND COSTS FOR PERSISTENT ASTHMA PATIENTS TREATED WITH BECLOMETHASONE DIPROPIONATE OR FLUTICASONE PROPIONATE

    May 1, 2009, 00:00

  • PMS47 GOLIMUMAB SIGNIFICANTLY IMPROVES PRODUCTIVITY IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS- RESULTS FROM THE PHASE 3 GO-RAISE STUDY

    May 1, 2009, 00:00

  • PND36 DRUG UTILISATION AND EXPENDITURE ASSOCIATED WITH TREATMENTS OF NEUROLOGICAL DISORDERS

    May 1, 2009, 00:00

  • PDB10 A COMPARISON OF ECONOMIC OUTCOMES BETWEEN ADHERENT AND NONADHERENT PATIENTS TREATED WITH ORAL ANTIDIABETIC MEDICATIONS

    May 1, 2009, 00:00

  • PHP70 ASSESSING THE EFFECT OF COST-SHARING ON EMERGENCY DEPARTMENT USE BY ECONOMICALLY DISADVANTAGED PERSONS

    May 1, 2009, 00:00

  • PCV10 COMPARATIVE EFFECTIVENESS OF INDIVIDUAL ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTS WITH CHF

    May 1, 2009, 00:00

  • PUK9 COST-EFFECTIVENESS ANALYSIS OF ALPHA-BLOCKER AND ANTIMUSCARINIC COMBINATION TREATMENT IN MEN WITH LOWER URINARY TRACT SYMPTOMS RELATED TO BENIGN PROSTATIC HYPERPLASIA AND OVERACTIVE BLADDER- APPLICATION TO THE UNITED KINGDOM

    May 1, 2009, 00:00

  • PCN94 LEVEL OF BREAST CANCER EARLY DETECTION AWARENESS OF BRAZILIAN WOMEN

    May 1, 2009, 00:00

  • PCN23 BUDGET IMPACT ANALYSIS OF DOCETAXEL REIMBURSEMENT IN INDUCTION THERAPY OF LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA IN POLAND

    May 1, 2009, 00:00

  • PCV64 ECONOMIC BURDEN OF ATHEROSCLEROSIS AMONG PATIENTS WITH TYPE-2 DIABETES MELLITUS

    May 1, 2009, 00:00

  • PMH24 PHARMACOECONOMIC EVALUATION OF PHARMACOLOGICAL INTERVENTIONS IN GENERALIZED ANXIETY DISORDERS (GAD) IN MEXICO

    May 1, 2009, 00:00

  • PCV73 INCREASED PATIENT THROUGHPUT AND REDUCTION IN LABORATORY STAFF AND LABOR INTENSITY WITH THE USE OF REGADENOSON

    May 1, 2009, 00:00

  • PHP55 TRENDS IN DESIGN CHARACTERISTICS OF BRIEF SUMMARY ON PRINT ADS OF PRESCRIPTION DRUGS- A FIVE YEAR STUDY

    May 1, 2009, 00:00

  • PIN58 DRUG UTILIZATION PATTERNS AND COSTS OF ANTIBIOTIC THERAPY AMONG PATIENTS WITH OR WITHOUT CANCER IN A 2000-BED MEDICAL CENTER IN TAIWAN

    May 1, 2009, 00:00

  • PSY23 ECONOMIC EVALUATION OF DARBEPOETIN ALFA AND EPOETIN IN HEMODIALYSIS PATIENTS WITH ANEMIA AND CHRONIC KIDNEY DISEASE

    May 1, 2009, 00:00

  • PIN31 THE ECONOMICS AND EPIDEMIOLOGY OF MENINGOCOCCAL INFECTION- A SYSTEMATIC LITERATURE REVIEW

    May 1, 2009, 00:00

  • PCV100 PATTERN OF CLOPIDOGREL USE IN PERCUTANEOUS CORONARY INTERVENTION PATIENTS

    May 1, 2009, 00:00

  • PMC40 METHODS FOR PERSONALIZED MEDICINE- FACTOR MIXTURE MODELS FOR INVESTIGATING DIFFERENTIAL RESPONSE TO TREATMENT

    May 1, 2009, 00:00

  • PIH6 DEVELOPING EVIDENCE-BASED TRADITIONAL CHINESE MEDICINE THROUGH OUTCOME RESEARCH

    May 1, 2009, 00:00

  • PCN11 LUNG CANCER IN THE CHINESE SMOKING POPULATION

    May 1, 2009, 00:00

  • PMC47 USE OF STABILIZED INVERSE PROPENSITY SCORES AS WEIGHTS TO DIRECTLY ESTIMATE RELATIVE RISK AND ITS CONFIDENCE INTERVALS

    May 1, 2009, 00:00

  • PCV83 FACTORS AFFECTING ADHERENCE TO ANTIHYPERTENSIVE MEDICATION IN A NIGERIAN POPULATION

    May 1, 2009, 00:00

  • PRS10 RETURN ON INVESTMENT FROM SMOKING CESSATION INSURANCE COVERAGE IN THE WORKPLACE- A CANADIAN EMPLOYERS PERSPECTIVE

    May 1, 2009, 00:00

  • PDB52 THE UTILITY OF A PRIOR-AUTHORIZATION REQUIREMENT FOR IMPLEMENTING RECOMMENDATIONS FOR HBA1C TESTING IN A MANAGED CARES SETTING IN ISRAEL

    May 1, 2009, 00:00

  • PHP19 MEDICATION COSTS AND UTILIZATION IN A HOSPICE CARE

    May 1, 2009, 00:00

  • PSS7 A PHARMACOECONOMIC APPROACH OF THE USE OF INTRAVENOUS ANTIBIOTIC THERAPY FOR COMPLICATED SKIN AND SKIN-STRUCTURE INFECTIONS IN PUBLIC HEALTH CARE INSTITUTIONS IN MEXICO

    May 1, 2009, 00:00

  • PMS14 THE RELATIONSHIP BETWEEN SURGICAL DELAY OVER 24 HOURS AND 30 DAYS MORTALITY FOLLOWING FEMORAL NECK FRACTURE IN THE PRESENCE OF DIFFERENT CO-MORBIDITIES

    May 1, 2009, 00:00

  • PMH48 BURDEN OF ILLNESS OF DEPRESSION SYMPTOMS AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS

    May 1, 2009, 00:00

  • PGI11 ECONOMIC EVALUATION OF INFLIXIMAB AND ADALIMUMAB FOR CROHNS DISEASE

    May 1, 2009, 00:00

  • PGI21 ASSESSMENT OF THE EFFECTIVENESS OF 'AFFINEX FLAT STOMACH' AFTER 14 DAYS OF TREATMENT

    May 1, 2009, 00:00

  • PSY37 THE OBESITY TRENDS IN GENERAL POPULATION OF THE REPUBLIC OF SERBIA

    May 1, 2009, 00:00

  • PMH4 PREVALENCE OF DEPRESSION IN EUROPE- A COMPARISON OF FIVE COUNTRIES

    May 1, 2009, 00:00

  • PHP7 ABOLITION OF PRESCRIPTION CO-PAYMENTS- AN ANALYSIS OF ITEMS DISPENSED IN WALES

    May 1, 2009, 00:00

  • PHP93 PRESCRIPTION PATTERNS OF CHINESE HERBAL PRODUCTS SUSPECTED OF CONTAINING ARISTOLOCHIC ACID- ANALYSIS OF REIMBURSEMENT DATA OF A COHORT FROM TAIWAN DURING 1997-2003

    May 1, 2009, 00:00

  • PRS38 CONTINUOUS TREATMENT WITH FIXED COMBINATION OF LABA/ICS CAN AVOID COSTS OF HOSPITALIZATION IN ASTHMA AND COPD IN GERMANY

    May 1, 2009, 00:00

  • PMC79 TRANSLATION OF THE PATIENT-REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM INTO SPANISH

    May 1, 2009, 00:00

  • PIN51 HOSPITAL LENGTH OF STAY AND COSTS ASSOCIATED WITH INAPPROPRIATE TREATMENT OF CANDIDEMIA IN THE ICU

    May 1, 2009, 00:00

  • PCN86 TEST-RETEST RELIABILITY OF AN INTERACTIVE VOICE RESPONSE (IVR) VERSION OF THE EQ-5D IN A SAMPLE OF CANCER SURVIVORS

    May 1, 2009, 00:00

  • PND40 EXPLORING THE IMPACT OF DISPENSING CHANNEL ON MEDICATION ADHERENCE AMONG MULTIPLE SCLEROSIS PATIENTS

    May 1, 2009, 00:00

  • PCN109 BREAST CANCER PREVALENCE AND HEALTH CARE UTILIZATION AND COST TRENDS AMONG FEE-FOR-SERVICE FEMALE RECIPIENTS IN A STATE MEDICAID PROGRAM

    May 1, 2009, 00:00

  • CO1 EVIDENCE-BASED TIME HORIZON FOR THE INTERVENTIONS IN PHARMACOECONOMIC MODELS

    May 1, 2009, 00:00

  • PCV1 EVALUATING CLINICAL OUTCOMES OF AN EMPLOYER SPONSERED MULTI CENTER DIABETES AND HYPERTENSION MEDICATION THERAPY MANAGEMENT PROGRAM (MTMP)

    May 1, 2009, 00:00

  • PCN51 PROJECTED LONG-TERM ECONOMIC OUTCOMES ASSOCIATED WITH BEVACIZUMAB TREATMENT IN PATIENTS WITH ADJUVANT TRIPLENEGATIVE BREAST CANCER TO INFORM EARLY DECISION MAKING

    May 1, 2009, 00:00

  • PCV104 ANALYSIS OF ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS IN THE US MEDICAID PROGRAM FROM 1991 TO 2007

    May 1, 2009, 00:00

  • PMH50 THE VALIDATION OF TURKISH VERSION OF PERSONAL AND SOCIAL PERFORMANCE SCALE (PSP)

    May 1, 2009, 00:00

  • PIH43 HOURLY AND ANNUAL OBJECTIVE PRODUCTIVITY (PRESENTEEISM) ACROSS SEVERAL DISEASES- BIPOLAR DISORDER, OTHER MENTAL DISORDERS, CHRONIC CONSTIPATION, FUNCTIONAL DYSPEPSIA, GERD, GOUT, AND INSOMNIA

    May 1, 2009, 00:00

  • PMH87 TREATMENT PATTERNS BY RACE/ETHNICITY AND INCOME LEVELS AMONG ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD) SUBJECTS TREATED WITH SHORT-, INTERMEDIATE-AND LONG-ACTING STIMULANTS

    May 1, 2009, 00:00

  • PSY25 MEDICAL TREATMENT COSTS ATTRIBUTABLE TO OBESITY IN PATIENTS WITH ASTHMA AMONG U.S. ADULTS

    May 1, 2009, 00:00

  • PDB2 A1C AND WEIGHT OUTCOMES FOLLOWING 6 MONTHS OF ANALOG BASAL INSULIN IN INSULIN NAVE PATIENTS WITH TYPE-2 DIABETES IN AN AMBULATORY CARE SETTING

    May 1, 2009, 00:00

  • PMH28 DIRECT COSTS OF PATIENTS WITH TREATMENT RESISTANT AND NON-TREATMENT RESISTANT MAJOR DEPRESSIVE DISORDER

    May 1, 2009, 00:00

  • PMC49 A FACTORIAL SIMULATION OF THE GAINS FROM AN EMPIRICAL BAYES APPROACH OVER CLASSICAL METHODS

    May 1, 2009, 00:00

  • PCV76 RELATIONSHIP BETWEEN HEALTH LITERACY, OUTCOME EXPECTATIONS, EFFICACY EXPECTATIONS AND MEDICATION ADHERENCE

    May 1, 2009, 00:00

  • PIN15 COMPARING COST-EFFECTIVENESS OF THE THREE- VERSUS TWO-DOSE VACCINATION PROTOCOL AGAINST HEPATITIS B IN ADOLESCENTS

    May 1, 2009, 00:00

  • PCN102 IMPACT OF RADIOTHERAPY SEQUENCE WITH SURGERY ON SURVIVAL FOR PATIENTS WITH RESECTABLE COLORECTAL CANCER

    May 1, 2009, 00:00

  • PDB9 THE EFFECTS OF SUSTAINED-RELEASE GLIPIZIDE VERSUS GLICLAZIDE FOR TYPE 2 DIABETES MELLITUS- A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS

    May 1, 2009, 00:00

  • PDB42 PERCEPTION VERSUS REALITY-CATEGORISATION OF PATIENT WEIGHT BY TYPE 2 DIABETES (T2DM) PATIENTS AND THEIR PHYSICIANS IN THE US AND EUROPE

    May 1, 2009, 00:00

  • PHP37 REGIONAL VARIATION IN MEDICAID ENROLLMENT AMONG MEDICAL EXPENDITURE PANEL SURVEY (MEPS) POPULATION

    May 1, 2009, 00:00

  • PSS23 PHYSICIANS AWARENESS, ATTITUDE, AND BEHAVIOR TO USE THE WAIT AND WATCH APPROACH FOR THE TREATMENT OF ACUTE OTITIS MEDIA

    May 1, 2009, 00:00

  • PRS27 ASTHMA-RELATED PRODUCTIVITY LOSSES IN ALBERTA, CANADA

    May 1, 2009, 00:00

  • PGI17 EXAMINATION OF PROTON PUMP INHIBITOR (PPI) UTILIZATION AMONG GASTROESOPHAGEAL REFLUX (GERD) PATIENTS USING ELECTRONIC MEDICAL RECORDS (EMR)

    May 1, 2009, 00:00

  • PMC71 APPLICATION AND FURTHER VALIDATION OF A PATIENT-REPORTED OUTCOME INSTRUMENT- PATIENT SATISFACTION WITH PHARMACEUTICAL CARE QUESTIONNAIRE

    May 1, 2009, 00:00

  • PMC91 REPORTING QUALITY OF DOUBLE-BLIND RANDOMIZED CONTROLLED TRIALS AND ITS ASSOCIATION WITH THE FUNDING AGENCY

    May 1, 2009, 00:00

  • PCV38 COST-EFFECTIVENESS OF RIVAROXABAN VERSUS ENOXAPARIN FOR PROPHYLAXIS AFTER TOTAL HIP OR TOTAL KNEE REPLACEMENT IN KOREA

    May 1, 2009, 00:00

  • PRS8 COSTS OF SMOKING IN SLOVAKIA FROM A PAYER PERSPECTIVE

    May 1, 2009, 00:00

  • PSY34 IMPACT OF OBESITY ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ASTHMA IN THE USA

    May 1, 2009, 00:00

  • PIH21 DRIVERS OF HEALTH CARE COSTS IN WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD)

    May 1, 2009, 00:00

  • MD6 PREDICTORS OF UTILIZATION OF ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS AMONG MEDICARE PART D ENROLLEES WITH DIABETES

    May 1, 2009, 00:00

  • PIH8 COMPARISON OF LEVONORGESTREL INTRAUTERINE SYSTEM (LNG-IUS) TO ORAL CONTRACEPTIVES (OC) ON CONTRACEPTION- A COST-EFFECTIVENESS ANALYSIS

    May 1, 2009, 00:00

  • PRS5 RELATIONSHIP BETWEEN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND DURATION OF CONTROLLER THERAPY AMONG A COMMERCIALLY INSURED POPULATION IN THE UNITED STATES

    May 1, 2009, 00:00

  • PCN26 COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS AND COSTS IN CANCER INPATIENTS RECEIVING CHEMOTHERAPY

    May 1, 2009, 00:00

  • PMS39 IMPAIRMENTS IN QUALITY OF LIFE, DAILY FUNCTION, AND WORK PRODUCTIVITY AND ACTIVITY IN RHEUMATOID ARTHRITIS PATIENTS WHO USE SUBCUTANEOUS BIOLOGIC THERAPIES

    May 1, 2009, 00:00

  • PIH13 COST-EFFECTIVENESS OF A SCHOOL-BASED TOBACCO-USE PREVENTION PROGRAM IN SPAIN

    May 1, 2009, 00:00

  • PMS13 PREVALENCE OF FIBROMYALGIA IN RUSSIA

    May 1, 2009, 00:00

  • PCN84 VALIDATION OF THE EUROQOL EQ-5D IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA (RR MCL)

    May 1, 2009, 00:00

  • PHP40 EVALUATING COST/EQUITY IN THE COLOMBIAN HEALTH SYSTEM, 1998-2005

    May 1, 2009, 00:00

  • PMS38 PATIENTS SUCCESS CRITERIA AND EXPECTATIONS IN FALLS REHABILITATION

    May 1, 2009, 00:00

  • CASE6 PILOT PROJECT- INTEGRATING ADMINISTRATIVE AND FINANCIAL DATABASES TO ESTIMATE PRICE OF HOSPITALIZATIONS

    May 1, 2009, 00:00

  • PMS5 FACTORS INFLUENCING THE LENGTH OF STAY AND TOTAL CHARGES FOR PEDIATRIC PATIENTS DIAGNOSED WITH OSTEOMYELITIS

    May 1, 2009, 00:00

  • PRS22 IMPACT OF APPROPRIATE THERAPY ON ASTHMA-RELATED HEALTH CARE UTILIZATION AND EXPENDITURES IN A MEDICAL POPULATION OF SEVERE ASTHMATIC PATIENTS

    May 1, 2009, 00:00

  • PCN78 PREFERENCES IN MULTIPLE MYELOMA TREATMENT-WHAT DO PHYSICIANS THINK?

    May 1, 2009, 00:00

  • PCV44 COST EFFECTIVENESS OF CLOPIDOGREL TREATMENT VERSUS ASPIRIN TREATMENT IN SOUTH KOREAN PATIENTS WITH ATHEROTHROBOSIS- RESULTS OF THE CAPRIE (CLOPIDOGREL VERSUS ASPIRIN IN PATIENTS AT RISK OF ISCHEMIC EVENTS) STUDY

    May 1, 2009, 00:00

  • PMC84 THE POWER OF ASSUMPTIONS

    May 1, 2009, 00:00

  • PCN69 COST-EFFECTIVENESS OF FIRST-LINE COMBINATION TREATMENT WITH BEVACIZUMAB PLUS FOLFIRI VERSUS FOLFIRI IN PATIENTS WITH METASTATIC COLORECTAL CANCER- A UK PERSPECTIVE

    May 1, 2009, 00:00

  • PCN57 ASSESSING THE MAJOR DRIVERS FOR THE INCREASED HEALTH CARE COSTS ASSOCIATED WITH PROSTATE CANCER

    May 1, 2009, 00:00

  • PHP2 PHARMACY BENEFIT DESIGN AND PATIENT DRUG SUBSTITUTION

    May 1, 2009, 00:00

  • PUK20 PROFILING COMMON CO-MORBIDITIES AND MEDICATIONS PRESCRIBED AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE

    May 1, 2009, 00:00

  • PHC2 SOCIOECONOMIC STATUS AND COST OF CARE IN THE ELDERLY UNDERGOING MAJOR ORTHOPEDIC SURGERY

    May 1, 2009, 00:00

  • PMC7 EFFECTS OF HETEROGENEITY ON THE ESTIMATION AND COMPARISON OF MEDICATION ERROR RATES

    May 1, 2009, 00:00

  • PDB33 DAILY AVERAGE CONSUMPTION OF BASAL INSULIN IN PATIENTS WITH TYPE 2 DIABETES

    May 1, 2009, 00:00

  • PCN106 THE IMPACT OF CANCER SCREENING GUIDELINE INFORMATION ON CANCER DETECTION

    May 1, 2009, 00:00

  • PMS19 DRUG UTILIZATION AND SPENDING TRENDS OF BISPHOSPHONATE MEDICATIONS MEDICAID PROGRAMS IN THE UNITED STATES

    May 1, 2009, 00:00

  • PIH10 COST EFFECTIVENESS OF ORAL BISPHOSPHONATES ADMINISTERED ON EXTENDED DOSING INTERVALS

    May 1, 2009, 00:00

  • PMH30 HOSPITALIZATION COSTS FOR SCHIZOPHRENIA RELAPSES IN A PUBLIC PSYCHIATRIC INSTITUTION

    May 1, 2009, 00:00

  • PMS54 THE EFFECTS OF THE PART D DOUGHNUT HOLE ON MEDICARE PATIENTS WHO REQUIRE HIGH-COST MEDICATIONS

    May 1, 2009, 00:00

  • PHC4 COST-EFFECTIVENESS OF PIMOBENDAN VERSUS BENAZEPRIL IN ACQUIRED MYXOMATOUS MITRAL VALVE DISEASE IN DOGS- AN ADAPTATION TO SWITZERLAND

    May 1, 2009, 00:00

  • CV1 COMPARISON OF CARDIOVASCULAR EVENT RATES IN SUBJECTS WITH TYPE-2 DIABETES MELLITUS WHO AUGMENTED FROM STATIN MONOTHERAPY TO STATIN PLUS FIBRATE COMBINATION THERAPY WITH THOSE WHO REMAINED ON STATIN MONOTHERAPY

    May 1, 2009, 00:00

  • PCN73 USING SHORT-TERM RESPONSE TO PREDICT LONG-TERM OUTCOMES IN PATIENTS WITH IMATINIB-RESISTENT OR IMATINIB-INTOLERANT CHRONIC MYELOID LEUKAEMIA

    May 1, 2009, 00:00

  • PSY12 TREATMENT OF TRANSFUSIONAL IRON OVERLOAD IN PATIENTS WITH MYELODYSPLASTIC SYNDROME OR SEVERE ANEMIA- DATA FROM MULTI-CENTER CLINICAL PRACTICES

    May 1, 2009, 00:00

  • PCV99 A LONGITUDINAL ANALYSIS OF ANGIOTENSIN RECEPTOR BLOCKER (ARB) PRESCRIBING PATTERNS UNDER A PRIOR-AUTHORIZATION REQUIREMENT

    May 1, 2009, 00:00

  • PUK13 COST-EFFECTIVENESS OF A RENAL HEALTH PROGRAM IN PATIENTS WITH HYPERTENSIVE AND/OR DIABETES INDUCED CHRONIC KIDNEY DISEASE

    May 1, 2009, 00:00

  • PCN66 COST OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY AMONG U.S. BREAST CANCER PATIENTS

    May 1, 2009, 00:00

  • PCV20 ESTIMATE THE 10-YEAR CARDIOVASCULAR RISK IN THE GENERAL PUBLIC OF HONG KONG

    May 1, 2009, 00:00

  • PDB57 MEDICATION NONADHERENCE AND POTENTIALLY AVOIDABLE HOSPITALIZATIONS AMONG PATIENTS WITH DIABETES

    May 1, 2009, 00:00

  • PHP82 USE OF INDIRECT COMPARISON IN HTA SUBMISSIONS

    May 1, 2009, 00:00

  • PCN45 PHARMACOECONOMIC EVALUATION OF THE USE OF SOMATOSTATIN ANALOGS HANDLING THE ASSOCIATED SYMPTOMS OF CARCINOID SYNDROME

    May 1, 2009, 00:00

  • PMH14 BUDGETARY IMPACT OF WELL DIRECTED USE OF PALIPERIDONE ER IN GERMANY

    May 1, 2009, 00:00

  • PDB32 CHANGES IN OPIOID USE AND ECONOMIC OUTCOMES AMONG DIABETIC PERIPHERAL NEUROPATHIC PAIN PATIENTS TREATED WITH DULOXETINE

    May 1, 2009, 00:00

  • PDB17 GLYCEMIC VARIABILITY AND COMPLICATIONS IN PATIENTS WITH DIABETES MELLITUS- EVIDENCE FROM A SYSTEMATIC REVIEW OF THE LITERATURE

    May 1, 2009, 00:00

  • PIN22 COST OF PNEUMOCOCCAL INFECTIONS AND COST-EFFECTIVENESS ANALYSIS OF PNEUMOCOCCAL VACCINATION IN TURKEY

    May 1, 2009, 00:00

  • PSS20 THE RELATIONSHIP BETWEEN SATISFACTION WITH VISION AND SPECTACLE INDEPENDENCE

    May 1, 2009, 00:00
  • «
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146 (current)
  • 147
  • 148
  • 149
  • 150
  • »